Cosmos Pharm stock trades at JPY 6,198 after fiscal results

Published on 10/04/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cosmos Pharm stock last traded at JPY 6,198 on October 2, 2026, while fiscal 2026 revenue reached JPY 1,099,583.0 million. Ten analysts set a Buy consensus.

Cosmos Pharm, JP3298400007, Illustration mit AI erstellt.

Cosmos Pharm (ISIN JP3298400007) last traded at JPY 6,198 on the Tokyo Stock Exchange at 3:30 p.m. JST on October 2, 2026, with a daily change of -0.21 percent. The latest fiscal figures give the stock a concrete operating reference as the company enters its new reporting year.

Fiscal revenue reaches JPY 1,099.6 billion

6ix identifies the latest full-year report as the fiscal year ended May 31, 2026. Cosmos Pharmaceutical Corporation generated revenue of JPY 1,099,583.0 million, up 8.72 percent from JPY 1,011,390.0 million in fiscal 2025, while operating profit reached JPY 42,353.0 million.

The annual gross profit was JPY 229,683.0 million, compared with JPY 213,281.0 million in fiscal 2025. That combination points to continued top-line expansion, although the operating profit increase was smaller than the revenue increase.

Quarterly sales provide the next test

Investing.com reports that the latest quarter delivered revenue of JPY 289,203.0 million, compared with JPY 273,205.0 million in the previous quarter. The increase was 5.9 percent, while net income rose from JPY 8,100.0 million to JPY 9,298.0 million.

Cosmos Pharmaceutical Corporation's investor-relations page lists monthly sales disclosures and an IR schedule alongside its financial materials. The company operates Japanese retail stores selling pharmaceuticals, cosmetics, food and daily necessities, giving store expansion and monthly sales an important role in the revenue trend.

Consensus target stands above the market

Investing.com lists a Buy consensus from 10 analysts, with 5 Buy ratings, 5 Hold ratings and 0 Sell ratings. The average 12-month price target is JPY 7,620.0, with a high of JPY 9,600.0 and a low of JPY 6,700.0; the average target lies 22.9 percent above the October 2 reference price.

The market snapshot shows JPY 491.2 billion in market capitalization and trading volume of 415,000 shares on October 2, 2026. The 52-week range was JPY 5,615 to JPY 8,590, placing the reference price 10.4 percent above the low and 27.9 percent below the high.

Cosmos Pharm stock stays below its yearly high

Cosmos Pharm stock therefore combines an 8.72 percent annual revenue increase with a valuation reference below the 52-week high. The next investor checkpoint is whether quarterly revenue growth and net income can maintain the pace shown in the latest reported quarter.